A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab

NCT07221838 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Myasthenia Gravis
gMG

Interventions

PROCEDURE: Oral Corticosteroid Tapering Schedule
DRUG: Ravulizumab
DRUG: Prednisone/Prednisolone

Sponsor

Alexion Pharmaceuticals, Inc.